| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |